Ameloblastic carcinoma: A systematic review
Journal of Oral Pathology & Medicine · 2024
DOI: 10.1111/jop.13517 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Journal of Oral Pathology & Medicine, 2024. Verfasst von Liam Robinson und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa. Hauptthemen laut MEDLINE: Odontogenic Tumors. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Background
Ameloblastic carcinoma (AC) is the most common odontogenic malignancy, constituting approximately 30% of cases in this category. Literature is sparse on malignant odontogenic neoplasms, with a large proportion of current knowledge derived from case reports or small case series.
Methods
A systematic review of case series/case reports of AC was conducted following the Preferred Reporting Items for Systematic Reviews and Meta‐analyses (PRISMA) Statement guidelines. Demographic and clinical information, including duration of the lesion, location, clinical presentation and radiologic features, were analysed. Additionally, the origin of the lesion (primary/secondary), Ki‐67 proliferation index, treatment performed, metastasis, tumour recurrence and prognosis were collected for analysis.
Results
A total of 126 studies, including 285 individual cases of AC, were included in this review. Patients presented with a near‐equal distribution of painless and painful swellings. ACs presented at a median age of 45 years, with a male‐to‐female ratio of 1:2. The mandible was most frequently involved, with rare cases extending to involve more than one region, including crossing the midline. Although most lesions presented with poorly‐demarcated borders (52.6%), unilocular lesions with well‐demarcated borders (47.4%) comprised a substantial number in the sample. The proliferation index was only reported in 27 cases, with a mean score of 42% and a wide range. The probability of tumour recurrence increased, and the survival probability decreased with prolonged follow‐up duration.
Conclusion
This study provides more comprehensive, up‐to‐date descriptive data on these rare odontogenic malignancies, aiding clinicians and Pathologists with the diagnosis and surgeons in their management of cases.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Pathology, School of Dentistry, Faculty of Health Sciences, University of Pretoria, Pretoria, South Africa.
- Members of an International Consortium on Odontogenic Tumours.
- Department of Paediatric Dentistry, School of Dentistry, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Department of Oral Surgery and Pathology, School of Dentistry, Federal University of Minas Gerais (UFMG), Belo Horizonte, Brazil.
- Liverpool Head and Neck Centre, Molecular and Clinical Cancer Medicine Unit, Faculty of Health and Life Sciences, University of Liverpool, Liverpool, UK.
ORCID-Profile: Liam Robinson, Lucas Guimarães Abreu, Felipe Paiva Fonseca, Keith D Hunter, Melvin A Ambele, Willie F P van Heerden
Zitieren
APA
Robinson, L., Abreu, L. G., Fonseca, F. P., Hunter, K. D., Ambele, M. A., & van Heerden, W. F. P. (2024). Ameloblastic carcinoma: A systematic review. Journal of Oral Pathology & Medicine. https://doi.org/10.1111/jop.13517
Vancouver
Robinson L, Abreu LG, Fonseca FP, Hunter KD, Ambele MA, van Heerden WFP. Ameloblastic carcinoma: A systematic review. Journal of Oral Pathology & Medicine. 2024. doi:10.1111/jop.13517
BibTeX
@article{Robinson2024,
author = {Robinson, Liam and Abreu, Lucas Guimarães and Fonseca, Felipe Paiva and Hunter, Keith D and Ambele, Melvin A and van Heerden, Willie F P},
title = {Ameloblastic carcinoma: A systematic review},
journal = {Journal of Oral Pathology & Medicine},
year = {2024},
doi = {10.1111/jop.13517}
}
EUVIMED